Bidness ETC |
NPS Pharmaceuticals Inc. (NPSP) Has Gapped Up Sharply On FDA News
NASDAQ (RTTNews.com) – A preliminary review by the FDA has found that NPS Pharmaceuticals Inc.'s ( NPSP ) Natpara reduced the need for calcium and vitamin D supplements in clinical studies. NPS Pharmaceuticals gapped open sharply higher Wednesday … NPS Pharmaceuticals Surges On FDA Panel Report |